SCHEMBL4173265

SCHEMBL4173265

CCc1cc2nncc(N3CCc4cc(OC)c(OC)cc4C3)c2cc1OC

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADRA1D P25100 1/20 0.46
ADRA1A P35348 1/20 0.46
ADRA1B P35368 1/20 0.46
RAB9A P51151 2/20 0.43
MAPT P10636 4/20 0.42
LMNA P02545 3/20 0.42
ALDH1A1 P00352 2/20 0.42
MAPK1 P28482 2/20 0.42
HTT P42858 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
MAOB P27338 4/20 0.42
KMT2A Q03164 2/20 0.42
PDE10A Q9Y233 1/20 0.41
POLB P06746 1/20 0.41
NPC1 O15118 1/20 0.41
PDGFRB P09619 1/20 0.40
MEN1 O00255 1/20 0.40
TP53 P04637 1/20 0.40
GAA P10253 1/20 0.40
HPGD P15428 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8230235 0.98 ADRA1D (0.43) ADRA1DADRA1AADRA1BRAB9AMAPT
SCHEMBL5244659 0.90 ADRA1D (0.55) ADRA1DADRA1AADRA1BRAB9AMAPT
Hydrochloric Acid SCHEMBL5292124 0.89 ADRA1D (0.54) ADRA1DADRA1AADRA1BRAB9AMAPT
SCHEMBL5301806 0.87 PDE4D (0.49) ADRA1DADRA1AADRA1BRAB9AMAPT
SCHEMBL5247398 0.83 ADRA1D (0.46) ADRA1DADRA1AADRA1BRAB9AMAPT
SCHEMBL5288680 0.80 PDE10A (0.53) ADRA1DADRA1AADRA1BMAPTLMNA
SCHEMBL5246573 0.79 PDE10A (0.46) ADRA1DADRA1AADRA1BRAB9AMAPT
SCHEMBL5287072 0.79 PDGFRB (0.47) ADRA1DADRA1AADRA1BRAB9AMAPT
SCHEMBL5301608 0.79 PDGFRB (0.47) ADRA1DADRA1AADRA1BRAB9AMAPT
SCHEMBL5247596 0.79 PDE10A (0.46) ADRA1DADRA1AADRA1BRAB9AMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090099175-A1 Phosphodiesterase 10 inhibitors MEMORY PHARMACEUTICALS CORPORATION 2009-04-16 US disclosed
US-20090099175-A1 Phosphodiesterase 10 inhibitors MEMORY PHARMACEUTICALS CORPORATION 2009-04-16 US disclosed
US-20090099175-A1 Phosphodiesterase 10 inhibitors MEMORY PHARMACEUTICALS CORPORATION 2009-04-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090099175-A1 Phosphodiesterase 10 inhibitors PDE7A, PDE7B, PDE10A ADRA1D 576/4885ADRA1A 819/4885ADRA1B 911/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.